@Article{Jackowski2009,
journal="Przegląd Kardiodiabetologiczny/Cardio-Diabetological Review",
issn="1896-9666",
year="2009",
title="Review paperThe usage of the \β-adrenolytic drugs by the patients with diabetes and coexisting  diseases",
abstract="Fifty years of experience with the \β-adrenolytic drugs provided the solid evidence to recognize their high medical status and importance. But there is still debate about the variuos effects of \β-adrenolytic drugs in cardiodiabetology. Diabetes is the metabolic disease that can have a negative impact on the cardiovascular system. Additionally, it can exacerbate already existing disease. The aim of this review is to explore the usage of the \β-adrenolytic drugs in the cardiodiabetology.",
author="Jackowski, Tomasz
and Bychowski, Jerzy",
pages="161--166",
url="https://www.termedia.pl/Review-paper-The-usage-of-the-946-adrenolytic-drugs-by-the-patients-with-diabetes-and-coexisting-diseases,47,14610,1,1.html"
}